Sage Therapeutics, Inc. (SAGE)
Market Cap | 651.17M |
Revenue (ttm) | 91.06M |
Net Income (ttm) | -503.14M |
Shares Out | 60.18M |
EPS (ttm) | -8.39 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 780,500 |
Open | 10.85 |
Previous Close | 11.03 |
Day's Range | 10.66 - 11.13 |
52-Week Range | 9.76 - 49.74 |
Beta | 0.92 |
Analysts | Hold |
Price Target | 18.39 (+69.96%) |
Earnings Date | Aug 5, 2024 |
About SAGE
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes brain health medicines. Its product candidates include ZULRESSO, a CIV injection for the treatment of postpartum depression (PPD) in adults; and ZURZUVAE, a neuroactive steroid, a positive allosteric modulator of GABAA receptors, targeting both synaptic and extrasynaptic GABAA receptors, for the treatment of postpartum depression. Its product pipeline also comprises SAGE-324, a compound that is in Phase II clinical trial to treat essential tremors, as well as has ... [Read more]
Financial Performance
In 2023, SAGE's revenue was $86.46 million, an increase of 1024.84% compared to the previous year's $7.69 million. Losses were -$541.49 million, 1.63% more than in 2022.
Financial StatementsAnalyst Forecast
According to 19 analysts, the average rating for SAGE stock is "Hold." The 12-month stock price forecast is $18.39, which is an increase of 69.96% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/a/o/press15-2507350.jpg)
Sage Therapeutics Inc Is Under Investigation By The Schall Law Firm For Possible Violations Of Securities Laws And Investors Who Incurred Losses Are Encouraged To Reach Out
LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,...
![](https://cdn.snapi.dev/images/v1/x/p/press11-2502241.jpg)
The Schall Law Firm Is Investigating Sage Therapeutics Inc For Potential Infringements Of Securities Laws And Encourages Investors Who Sustained Losses To Make Contact
LOS ANGELES, CA / ACCESSWIRE / June 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics...
![](https://cdn.snapi.dev/images/v1/m/n/press17-2498667.jpg)
The Schall Law Firm Is Probing Sage Therapeutics Inc For Possible Breaches Of Securities Regulations And Urges Investors Who Endured Losses To Reach Out
LOS ANGELES, CA / ACCESSWIRE / June 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics...
![](https://cdn.snapi.dev/images/v1/y/v/press6-2496101.jpg)
Sage Therapeutics Inc Is Being Probed By The Schall Law Firm For Potential Securities Law Violations And Investors With Losses Are Encouraged To Reach Out
LOS ANGELES, CA / ACCESSWIRE / June 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics...
![](https://cdn.snapi.dev/images/v1/g/r/press2-2493893.jpg)
Sage Therapeutics Inc Is Under Investigation By The Schall Law Firm For Possible Securities Law Breaches And Investors With Losses Are Urged To Connect
LOS ANGELES, CA / ACCESSWIRE / June 24, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics...
![](https://cdn.snapi.dev/images/v1/q/6/press10-2491898.jpg)
The Schall Law Firm Investigates Sage Therapeutics Inc For Potential Violations Of Securities Laws And Encourages Investors Who Have Suffered Losses To Get In Touch
LOS ANGELES, CA / ACCESSWIRE / June 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics...
![](https://cdn.snapi.dev/images/v1/w/w/press10-2491464.jpg)
The Schall Law Firm Probes Sage Therapeutics Inc For Possible Breaches Of Securities Laws And Invites Loss Suffering Investors To Connect With The Firm
LOS ANGELES, CA / ACCESSWIRE / June 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics...
![](https://cdn.snapi.dev/images/v1/k/v/press1-2487003.jpg)
The Schall Law Firm Is Investigating Sage Therapeutics Inc For Potential Violations Of Securities Laws Investors With Losses Are Encouraged To Contact The Firm
LOS ANGELES, CA / ACCESSWIRE / June 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics...
![](https://cdn.snapi.dev/images/v1/5/j/press10-2485721.jpg)
Sage Therapeutics Inc Is Being Probed By The Schall Law Firm For Possible Securities Breaches Investors Who Have Suffered Losses Are Urged To Reach Out
LOS ANGELES, CA / ACCESSWIRE / June 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics...
![](https://cdn.snapi.dev/images/v1/k/a/press18-2483418.jpg)
Sage Therapeutics Inc. Under Investigation By Schall Law Firm For Potential Securities Violations. Investors Who Lost Money Encouraged To Contact The Firm
LOS ANGELES, CA / ACCESSWIRE / June 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics...
![](https://cdn.snapi.dev/images/v1/o/q/press9-2474713.jpg)
Allegations Against Sage Therapeutics, Inc.: Schall Law Firm Initiates Probe And Encourages Impacted Investors To Reach Out
LOS ANGELES, CA / ACCESSWIRE / June 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics...
![](https://cdn.snapi.dev/images/v1/k/e/biotech4-2472934.jpg)
Sage Therapeutics' rare disease drug meets main goal in mid-stage study
Sage Therapeutics said on Tuesday its experimental drug met the main goal of a mid-stage study in patients with a type of rare disease known as Huntington's disease.
![](https://cdn.snapi.dev/images/v1/l/d/press10-2472801.jpg)
Sage Therapeutics Announces Phase 2 SURVEYOR Study Reinforces Cognitive Impact of Huntington's Disease
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics announced today topline results from the Phase 2 SURVEYOR Study. The study met its primary endpoint demonstrating a statistically significant diffe...
![](https://cdn.snapi.dev/images/v1/h/v/press11-2470219.jpg)
Charges Raised Against Sage Therapeutics, Inc.: Schall Law Firm Launches Investigation And Invites Impacted Investors To Participate
LOS ANGELES, CA / ACCESSWIRE / June 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,...
![](https://cdn.snapi.dev/images/v1/7/d/press4-2469814.jpg)
Allegations Made Against Sage Therapeutics, Inc.: Schall Law Firm Commences Probe And Calls On Impacted Investors To Engage
LOS ANGELES, CA / ACCESSWIRE / June 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,...
![](https://cdn.snapi.dev/images/v1/0/x/press9-2469427.jpg)
Accusations Against Sage Therapeutics, Inc.: Schall Law Firm Begins Investigation And Invites Affected Investors To Connect
LOS ANGELES, CA / ACCESSWIRE / June 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,...
![](https://cdn.snapi.dev/images/v1/e/q/press7-2466908.jpg)
Allegations Against Sage Therapeutics, Inc.: Schall Law Firm Initiates Inquiry and Encourages Impacted Investors to Reach Out
LOS ANGELES, CA / ACCESSWIRE / June 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,...
![](https://cdn.snapi.dev/images/v1/q/l/press15-2464540.jpg)
Sage Therapeutics, Inc. Allegations: Schall Law Firm Undertakes Investigation and Urges Affected Investors to Connect
LOS ANGELES, CA / ACCESSWIRE / June 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,...
![](https://cdn.snapi.dev/images/v1/b/p/conf6-2463140.jpg)
Sage Therapeutics to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will...
![](https://cdn.snapi.dev/images/v1/l/m/press5-2462371.jpg)
The Schall Law Firm is undertaking an investigation into allegations against Sage Therapeutics, Inc. and is urging investors who have incurred losses to make contact
LOS ANGELES, CA / ACCESSWIRE / June 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,...
![](https://cdn.snapi.dev/images/v1/9/m/press17-2460361.jpg)
SAGE CRUCIAL INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Sage Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,...
![](https://cdn.snapi.dev/images/v1/t/v/press19-2458074.jpg)
IMPORTANT ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sage Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,...
![](https://cdn.snapi.dev/images/v1/z/0/press14-2457715.jpg)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors Sage Therapeutics, Inc. - SAGE
NEW YORK, NY / ACCESSWIRE / June 1, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. ("Sage" or the "Company") (NASDAQ:SAGE). Such investors are advised t...
![](https://cdn.snapi.dev/images/v1/4/o/press19-2457606.jpg)
IMPORTANT ACTION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against Sage Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,...
![](https://cdn.snapi.dev/images/v1/6/g/press11-2457208.jpg)
IMPORTANT ACTION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Sage Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Sage Therapeutics,...